Endo uses carrots for Xiaflex ad launch to show the effects of Peyronie’s diseasenews2021-11-05T16:43:32+00:00November 5th, 2021|Fierce Pharma|
Endo turns to carrots for Xiaflex ad launch to depict the effects of Peyronie’s diseasenews2021-11-05T16:43:32+00:00November 5th, 2021|Fierce Pharma|
Emergent loses out on $180M as U.S. cancels COVID-19 vaccine production contractnews2021-11-05T15:32:43+00:00November 5th, 2021|Fierce Pharma|
Democrats’ drug pricing deal is ‘not a bad outcome’ for pharma, analysts writenews2021-11-05T15:14:41+00:00November 5th, 2021|Fierce Pharma|
Johnson & Johnson faces high-stakes hearing over ‘Texas Two Step’ talc strategy: reportnews2021-11-05T14:41:49+00:00November 5th, 2021|Fierce Pharma|
Deciphera misses blockbuster opportunity as Qinlock fails to top Pfizer’s Sutent in rare stomach cancernews2021-11-05T14:41:38+00:00November 5th, 2021|Fierce Pharma|
With ACIP recommendation, is tiny Dynavax set to win the hepatitis B sweepstakes with Heplisav-B?news2021-11-05T11:18:25+00:00November 5th, 2021|Fierce Pharma|
Fierce Pharma Asia—Legend, J&J’s CAR-T delay; BeiGene’s Brukinsa data; Samsung Biologics CEO interviewnews2021-11-05T10:24:17+00:00November 5th, 2021|Fierce Pharma|
What do millennials and boomers have in common? Healthcare consumer behaviors, it turns outnews2021-11-04T21:31:16+00:00November 4th, 2021|Fierce Pharma|
Surprise COVID-19 antibody sales of $804M help Regeneron trounce expectations in third quarternews2021-11-04T15:06:10+00:00November 4th, 2021|Fierce Pharma|
